The pharmaceutical industry is constantly changing. Mergers and reorganisations are commonplace, new economies are emerging, prices are under pressure and, in addition, there are ever-changing and more stringent regulatory requirements. These factors force pharmaceutical companies to be efficient and competitive in their production, making innovation a necessity in areas such as production processes. These innovations are related both to cost savings (energy efficiency, reduced space, fewer human operations, reduced waste production and concentration on production of semi-finished products) and to compliance with new legislation. This challenging environment demands that pharmaceutical companies maintain a 'top-of-the-class’ position and that specialist suppliers of production resources are constantly innovating.
Johan Klootwijk, CEO Inno4Life: "We are experienced in system and module development. Inno4Life brings knowledge and skills in response to the demands of the industry.
We specialize in complex 'engineering-to-order projects'. Our ambition is to be recognized as an international supplier of automated production equipment, by leading the way in the delivery of client-specific, innovative solutions, based on exceptional customer service and ‘value for money’. With ZIF's investment of capital and knowledge, we will be able to realize our ambitions for growth.”
Johan Sebregts, fund manager at Zeeuws Investment Fund: "By investing in Inno4Life,
we have added another great company to the ZIF portfolio. Thanks to our participation, Inno4Life can take on additional highly qualified staff, enabling the large number of acquired projects to be implemented and new projects to be realized. Through the combination of its unique technological expertise, the experience of a motivated organization and its extensive client portfolio, we are confident that Inno4Life will realize its potential for growth."
Inno4Life is established in 2010 by Johan Klootwijk and Wouter Hutzezon. Both of whom have gained extensive experience in the Life Sciences sector over the last 15 years.
More information about Inno4Life.